Merck & Co., Inc. (MRK) vs Micron Technology, Inc. (MU)

Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.

Micron Technology is one of the world’s largest semiconductor companies, focused on memory and storage chips. Its main source of revenue comes from dynamic random access memory (DRAM), while it also maintains smaller exposure to NAND flash memory. Micron serves a global customer base, supplying chips for data centers, mobile devices, consumer electronics, as well as industrial and automotive applications. The company operates as a vertically integrated business.